Pathogen Inactivation Technologies
- Wednesday, 26 October 2011
Although there are highly sensitive methods for pathogen detection in donor blood, the risk of infection via transfusion remains. A customer seeks methods to inactivate all known and unknown blood-borne pathogens in blood products, especially where those technologies can be used for whole blood or red blood cells. A pathogen agent should be able to inactivate multiple infection-agent forms, and a proposed solution must work on all three blood components: red blood cells, plasma, and platelets.